157 related articles for article (PubMed ID: 6282522)
1. Accumulation of Tc-99m phosphorus compounds in medullary carcinoma of the thyroid: report of two cases.
Shigeno C; Fukunaga M; Yamamoto I; Dokoh S; Morita R; Hino M; Torizuka K
Clin Nucl Med; 1982 Jun; 7(6):297-8. PubMed ID: 6282522
[No Abstract] [Full Text] [Related]
2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
3. The bone scan as a tumour marker in prostatic carcinoma.
Chisholm GD; Stone AR; Beynon LL; Merrick MV
Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
5. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
[No Abstract] [Full Text] [Related]
6. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
Fogelman I; Bessent RG
Eur J Nucl Med; 1981; 6(5):235. PubMed ID: 6265217
[No Abstract] [Full Text] [Related]
7. [Isotopic localization of hepatic metastasis of medullary carcinoma of the thyroid with Tc-99 pyrophosphate].
Salmerón de Diego J; Bittini Copano A; Domínguez Montero P; Jara Albarrán A
Med Clin (Barc); 1985 Sep; 85(9):385. PubMed ID: 3001450
[No Abstract] [Full Text] [Related]
8. Optimizing the performance and interpretation of bone scans.
Muroff LR
Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
[No Abstract] [Full Text] [Related]
9. Myocardial uptake. An unexpected finding in an oncology follow-up.
Boedecker RA; Blake DG; Sty JR; Riegert MR
Clin Nucl Med; 1983 Aug; 8(8):358-9. PubMed ID: 6226469
[No Abstract] [Full Text] [Related]
10. False-positive Tc-99m pentavalent DMSA uptake in the imaging of medullary carcinoma of the thyroid.
Lette J; Monier D; Ledoux R; Levasseur A
Clin Nucl Med; 1991 Feb; 16(2):136-7. PubMed ID: 1848495
[No Abstract] [Full Text] [Related]
11. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
12. Radiopharmaceuticals for myocardial infarct imaging: a clinical comparison of 99Tcm-pyrophosphate and 99Tcm-dimethylaminomethylene diphosphonate.
Bell D; Millar AM; Grayshan R; Muir AL
Br J Radiol; 1988 Jul; 61(727):646-8. PubMed ID: 2841991
[No Abstract] [Full Text] [Related]
13. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
14. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report.
O'Driscoll CM; Baker F; Casey MJ; Duffy GJ
J Nucl Med; 1991 Dec; 32(12):2281-3. PubMed ID: 1744716
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
[No Abstract] [Full Text] [Related]
16. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
17. Myocardial infarct imaging: superiority of inorganic agents over organic diphosphonates.
Logic JR; Meyer-Pavel CM; Blackman J
J Nucl Med; 1981 Jul; 22(7):659-70. PubMed ID: 6265610
[No Abstract] [Full Text] [Related]
18. Nuclear medicine: implications for podiatry.
Shuer ML; Hartshorne MF; Peters VJ
J Am Podiatr Med Assoc; 1985 Feb; 75(2):90-8. PubMed ID: 2984408
[No Abstract] [Full Text] [Related]
19. Uptake of Tc-99m sestamibi and Tc-99m MDP in anaplastic carcinoma of the thyroid (nondiagnostic CT and ultrasound scans).
Montes TC; Muñoz C; Rivero JI; Mota JA; Pustilnik N; Garcia F
Clin Nucl Med; 1999 May; 24(5):355-6. PubMed ID: 10232478
[No Abstract] [Full Text] [Related]
20. New vistas on bone scintigraphy.
Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
